logo

Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update

  a week ago   
post image
SAN DIEGO, Nov. 05, 2024 ( GLOBE NEWSWIRE ) -- AnaptysBio, Inc. ( Nasdaq: ANAB ) , a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial results for the third quarter ended Sept. 30, 2024 and provided a business update.
Ticker Sentiment Impact
ANAB
Neutral
5 %